Novellia, a healthtech startup based in New York, has successfully secured $18 million in Series A funding to enhance its Patient-Powered Data Platform, aimed at improving access to patient-consented health data for pharmaceutical research.
This funding round, led by Spark Capital with contributions from Khosla Ventures, Acrew Capital, Bling Capital, and TMV, brings Novellia's total funding to $28 million since its inception in 2023. The company has developed a platform that enables patients to securely gather and manage their medical records from various healthcare providers across the U.S., allowing them to consolidate up to 20 years of health data in seconds.
In addition to the funding announcement, Novellia launched a mobile application designed to enhance patient access to its platform. The startup emphasizes a model that prioritizes voluntary patient participation, allowing individuals to decide if they want to share their health information for research while ensuring that the data is anonymized before being utilized by pharmaceutical and life sciences organizations.
Novellia's innovative approach also incorporates advanced natural language processing to analyze unstructured clinical data, such as physician notes and diagnostic reports. This capability aims to generate research-ready datasets that provide valuable insights into clinical decision-making and patient outcomes. With the new capital, Novellia intends to further scale its platform, improve its AI capabilities, and increase patient engagement in research initiatives.